| Sheri L Guenther, PMHP | |
|
444 S 44th St, Omaha, NE 68131-3727 | |
| (402) 559-8943 | |
| (402) 559-5737 |
| Full Name | Sheri L Guenther |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 444 S 44th St, Omaha, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003175076 | NPI | - | NPPES |
| 10025287200 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 9641 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheri L Guenther, PMHP 985450 Nebraska Medical Ctr, Omaha, NE 68198-5450 Ph: (402) 559-8943 | Sheri L Guenther, PMHP 444 S 44th St, Omaha, NE 68131-3727 Ph: (402) 559-8943 |
News Archive
The U.S. National Science Advisory Board for Biosecurity on "Tuesday asked two scientific journals to leave out data from research studies on a lab-made version of bird flu that could spread more easily to humans, fearing it could be used as a potential weapon," Reuters reports.
Dayan B. Goodenowe and colleagues report in the November 2007 issue of the Journal of Lipid Research that people with Alzheimer's disease and related conditions exhibit decreased blood levels of an important brain chemical called ethanolamine plasmalogen, even at the very early stages of the disease.
Threshold Pharmaceuticals, Inc., today announced two preclinical presentations on its clinical stage hypoxia-activated prodrug, TH-302, at the American Association for Cancer Research Translational Cancer Medicine Meeting, being held July 11 to 14, 2010, in San Francisco, CA. The preclinical presentations describe new findings regarding the efficacy of TH-302 when combined with multi-kinase inhibitors that inhibit VEGF signaling, as well as the efficacy of TH-302 in combination with gemcitabine in models of pancreatic cancer.
Researchers from Molecular Biometrics, Inc. presented new data this week demonstrating that the company's ViaMetrics-E procedure more accurately predicts implantation rates in single embryo transfer (SET) cycles for patients undergoing infertility treatment. ViaMetrics-E is a rapid, non-invasive procedure used to enhance in vitro fertilization (IVF) outcomes by identifying viable embryos having the greatest reproductive potential.
› Verified 4 days ago
Jennifer Ross, M.A., PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2205 S 10th St, Suite 328, Omaha, NE 68108 Phone: 402-504-4102 | |
Monica L Blizek, LIMHP, CMSW, LADC Counselor Medicare: Medicare Enrolled Practice Location: 8502 Mormon Bridge Rd, Omaha, NE 68152 Phone: 402-991-8509 Fax: 402-455-7050 | |
Kate Anderson, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 8922 Cuming St, Omaha, NE 68114 Phone: 402-926-4373 Fax: 402-926-3898 | |
Adriana Niemann, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 4920 S 30th St, Suite 103, Omaha, NE 68107 Phone: 402-734-4110 | |
Ms. Diana M Shaw, LMHP, RPT Counselor Medicare: Not Enrolled in Medicare Practice Location: 820 S 75th St, Omaha, NE 68114 Phone: 402-391-2477 | |
Dr. Alan Luis Hensley, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 11329 P St # 108, Omaha, NE 68137 Phone: 402-650-1101 Fax: 402-597-2122 |